Is this you?
Request access for Synergy Research Centers with your @synergyresearchcenters.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Synergy Research Centers
Unclaimed profileSite Network · Rogers, AR and Lemon Grove, CA · ~2 sites
Intera lens
ICP 5Lift (cardio sample) 0.06Recruit soph 0.86
Quality Scorecard (1–100)
Overall66Recruit73Ops69Sponsor60Ther57
Performance (observed)
Historical trials
128
Completed
90
Terminated/Withdrawn
18
Completion rate
83%
Active now
20
Phase 2
37
Phase 3
83
Realized enrollment
218,255
First study year
2003
Years active
23
Match confidence
high
Enrollment velocity (inf)
9,489
Therapeutic
Areas
Psychiatry, neurology, internal medicine, depression, schizophrenia, diabetes, migraines
Specialties
Depression, Schizophrenia, Diabetes, psychiatric/CNS conditions
Breadth (conditions)
102
Languages
English
States
AR, CA
Recruitment (web observed)
Meta Pixel
Yes
Facebook Ads
Yes
Google Ads
Yes
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Yes - blog posts on clinical trials and conditions
Capability notes
Patient-focused recruitment with ongoing enrollment emphasis
Relationships
Sponsors
Pfizer; Otsuka Pharmaceutical Development & Commercialization, Inc.; Naurex, Inc, an affiliate of Allergan plc; Shire; Eli Lilly and Company; Sumitomo Pharma America, Inc.
CROs
Parexel; Teva Branded Pharmaceutical Products R&D, Inc.
Partnerships
ERG Network member
Owner / parent
Part of ERG (Evolution Research Group)
Expansion
Y (Rogers AR, Lemon Grove/San Diego CA locations)
Capacity & people
Investigators
—
Coordinators
—
CEO
Woody Woodaman
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Tech & DCT
eSource
Yes
Builds tech
Vendors (MyTrial App)
Home visits
N
DCT / decentralized
N
Tech stack
MyTrial App for patient participation management
Recruiting visible
Y
Notes
Small 2-site network; limited geographic reach (AR, CA); recruiting visibly but limited scale. Moderate fit for Intera—smaller network but shows recruitment-focused approach and patient engagement. Limited therapeutic breadth. [Validated: 2 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 0.42Liftability 0.06Overall66
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.